About | Free Trial

Last Update

2015-09-23T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Matthew Pollman?

Dr. Matthew Pollman

Chairman

Guided Interventions Inc

HQ Phone: (631) 839-1774

Guided Interventions Inc

25 Health Sciences Dr. S 104

Stony Brook, New York 11790

United States

Find other employees at this company (-1)

Background Information

Employment History

Founder, President and CSO
CV Ingenuity Corp

Affiliations

Member of the Advisory Board
Global Cardiovascular Innovation Center

Board Member
Juventas Therapeutics Inc

Full-Time Faculty Member
Morehouse School of Medicine

Full-Time Faculty Member
Harvard Medical School

Education

M.D

M.S.

Web References (22 Total References)


Guided Interventions was ...

www.guidedinterventions.com [cached]

Guided Interventions was founded by Dr. Pollman and Reinhard Warnking in 2011 with the vision to create a medical device company developing enabling technologies designed to maximize efficacy, minimize risk and reduce the cost of interventional procedures.

...
Matthew Pollman, Chairman


Matthew Pollman, MD, has ...

www.ncai-cc.ccf.org [cached]

Matthew Pollman, MD, has held a number of leadership positions in the development of cardiovascular therapeutics and diagnostics. He has most recently served as Medical Director, R&D, for Abbott Vascular. In this role, Dr. Pollman was the principal medical and scientific advisor for the R&D and Business Development organizations. Prior to this role, Dr. Pollman was the Director of New Ventures, Guidant Corporation where he led a multi-disciplinary in-house start-up incubator tasked with identifying, exploring and incubating through PhaseI/PhaseII clinical trials, novel therapeutic opportunities utilizing emerging device or combination product technologies. Dr. Pollman has also directed therapeutic/diagnostic target discovery and development efforts as Director of Cardiovascular Biology and Molecular Medicine for Millennium Pharmaceuticals. Dr. Pollman is a cardiologist and cardiovascular molecular biologist and has authored numerous peer-reviewed journal articles. He has served on the faculties of Harvard Medical School and Morehouse School of Medicine.


NIH Center for Accelerated Innovations (NCAI)

www.ncai-cc.ccf.org [cached]

Matt Pollman, MD Consultant, Cardiovascular Therapeutic and Diagnostics


Commercialization Advisory Board | GCIC | Global Cardiovascular Innovation Center in Cleveland, Ohio

gcic.org [cached]

Matt Pollman, MD

Consultant, Cardiovascular Therapeutic and Diagnostics
...
Matthew Pollman, consultant, has held a number of leadership positions in the development of cardiovascular therapeutics and diagnostics. He has most recently served as Medical Director, R&D, for Abbott Vascular. In this role, Dr. Pollman was the principal medical and scientific advisor for the R&D and Business Development organizations. Prior to this role, Dr. Pollman was the Director of New Ventures, Guidant Corporation where he led a multi-disciplinary in-house start-up incubator tasked with identifying, exploring and incubating through PhI/PhII clinical trials, novel therapeutic opportunities utilizing emerging device or combination product technologies. Dr. Pollman has also directed therapeutic/diagnostic target discovery and development efforts as Director of Cardiovascular Biology and Molecular Medicine for Millennium Pharmaceuticals. Dr. Pollman is a cardiologist and cardiovascular molecular biologist and has authored numerous peer-reviewed journal articles. He has served on the faculties of Harvard Medical School and Morehouse School of Medicine.


Matthew Pollman, M.D. - ...

juventasinc.com [cached]

Matthew Pollman, M.D. - Matthew Pollman, M.D. is a cardiologist and cardiovascular molecular biologist with over ten years of experience leading R&D initiatives in the biotechnology, diagnostics, and medical devices healthcare arenas. He is currently the Chairman of Guided Interventions, LLC, a startup company developing a product to help cardiologists better assess the physiological impact of coronary artery blockages. Prior to this latest venture, Dr. Pollman served as Founder, President and Chief Scientific Officer of CV Ingenuity, an early stage company developing a combination drug/device therapy for the treatment of cardiovascular disease, recently acquired by Covidien. Additionally, he has served as Medical Director, Research and Development, Abbott Vascular serving as principal medical and scientific strategist and advisor for the R&D pipeline and Business Development portfolios; guiding both internal and external technology investments. Prior to Abbott's acquisition of Guidant Corporation, Dr. Pollman directed their New Ventures group, a 30+ member in-house start-up incubator responsible for identifying, exploring and incubating significant new business opportunities. Dr. Pollman received his medical training at the University of California San Francisco, Stanford University and Brigham and Women's Hospital. He has served as a full-time faculty member at Harvard Medical School and Morehouse School of Medicine.

Similar Profiles

Other People with this Name

Other people with the name Pollman

Heather Pollman
State Farm Mutual Automobile Insurance Company

Terrill Pollman
UNLV

Mia Pollman
Lamar School

Kathy Pollman
Graphic Packaging International , Inc.

Gene Pollman
Missouri Military Memorial Foundation

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory